📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
5
RECENT COVERAGE · 3 ARTICLES
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
FDMT announced completion of enrollment for 4FRONT-2, a pivotal Phase 3 trial testing 4D-150 for wet age-related macular degeneration...
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
4D Molecular Therapeutics (FDMT) has secured a substantial $200 million credit facility from Hercules Capital (HTGC), a specialized...
4DMT Announces New Employment Inducement Grants
4DMT announced routine employment inducement grants of 66,900 Restricted Stock Units (RSUs) to seven new non-executive employees on June...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice